Long-Term Follow-Up Study of Patients with Spinal Muscular Atrophy Receiving Risdiplam Treatment

Go Back to All Clinical Trials

Long-Term Follow-Up Study of Patients with Spinal Muscular Atrophy Receiving Risdiplam Treatment

Brief description of study

This study will evaluate the long-term safety and effectiveness of risdiplam (Evrysdi?), prescribed on the basis of the U.S. Package Insert (USPI) and clinician judgement, in adult and pediatric spinal muscular atrophy (SMA) patients.

Clinical Study Identifier: s22-00184

Principal Investigator: Mary-Lynn Y Chu.

Other Investigator: Patrick Kwon.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies